ARMOTRAZ TABLET

Armotraz Tablet contains anastrozole, a prescription aromatase inhibitor widely used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. This anticancer tablet plays a key role in hormone therapy by targeting estrogen-dependent tumor growth. Armotraz is commonly included in long-term breast cancer management plans under specialist supervision

Anastrozole works by reducing estrogen levels in the body, which helps slow or stop the growth of cancer cells that rely on estrogen for survival. Armotraz 1 mg tablet is effective in lowering the risk of cancer progression and recurrence. Its oral tablet form ensures convenient dosing, making it suitable for extended treatment durations as advised by an oncologist.

Manufactured under strict WHO-GMP quality standards, Armotraz 1 mg Tablet ensures consistent safety, efficacy, and reliability. It is a trusted option in hormonal therapy for breast cancer and should be taken strictly as prescribed by a healthcare professional. This anastrozole medicine supports effective long-term cancer control when used as part of a comprehensive oncology treatment plan.

Product Features

• Hormonal anticancer therapy tablet
• Contains Anastrozole 1 mg
• Aromatase inhibitor for breast cancer treatment
• Used in postmenopausal women
• Oral tablet dosage form
• Suitable for long-term hormonal therapy
• Manufactured under strict pharmaceutical quality standards
• Prescription-required oncology medicine

How It Helps

• Lowers estrogen levels to slow cancer cell growth
• Helps treat hormone receptor-positive breast cancer
• Reduces risk of cancer progression and recurrence
• Supports long-term hormonal therapy under medical supervision